Innovations for Next-Generation Antibody-Drug Conjugates
Springer Nature Switzerland AG, 2019
172,25 €On orderDelivery: 2-3 weeks
While the book primarily addresses ADCs for solid tumors, the last chapter explores the emerging interest in using ADCs to treat other diseases. The therapeutic rationale of ADCs is strong: to direct small molecules to the desired site of action (and away from normal tissues) by conjugation to antibodies or other targeting moieties.
- ISBN-13
- 9783030086275
- ISBN-10
- 3030086275
- Publisher
- Springer Nature Switzerland AG
- Year
- 2019
- Publication date
- 2019-02-08
- Pages
- 357
- Dimensions
- 235x155x